Breaking
UP-developed Covid-19 test kits approved for commercial use
https://www.facebook.com/dostSecFTP/photos/a.848839558600943/1551235508361341/?type=3&__xts__%5B0%5D=68.ARCiwcMNpNJyDzZy-5tECS_IAQI6-HiugCHY5mI2TRxD9GZ7YAYPmIJQuJvQx1rHLIQ2wwLEBAESV6mqy29Lvf-VsQ4J8qq44TM66ZzPJGJEcZEKfn-NM0ltqkHVfdbAw6EHbR8_16ek0rkb-kIx2qFGdGohb3MlkjSzcGrnerGXhzXbH37FM6jrNCFG6TI_sN1GAvlNV5GYsi7XDjyVVK0XvrUQdiU-u33FCy799Qh9p9Io4QlJO8q1PdFJSy0q8fQQXT4sDSCY1eWILzgdZXbGn2pqNjYRldHBIAV8DZ7hYd9txzll7Md8H1ylu-9suzW5NyAXib2Auu1GP1-K1eS64A&__tn__=-R
MANILA— The Food and Drug Administration (FDA) has approved the coronavirus disease 2019 (Covid-19) test kits developed by the University of the Philippines-National Institutes of Health (UP-NIH).
“The Food and Drug Administration (FDA) has now approved the Real-Time PCR for the detection of COVID-19 manufactured by the Manila HealthTek, Inc. for commercial use,” the FDA said in an advisory on Friday night.
The UP-developed test kit was previously approved by the FDA for field trial.
Upon the company’s submission of necessary requirements, the FDA issued a certification for the COVID-19 test kit “to be allowed for commercial use”.
READ: UP-NIH to do 1K tests per week with coronavirus detection kit
“This is the first locally made PCR based COVID-19 test kit approved by the FDA which was developed in collaboration with the University of the Philippines-National Institute of Health (UP-NIH), funded by the Department of Science and Technology (DOST),” the FDA said.
Aside from the locally-made PCR based test kit, the FDA has also approved one additional rapid test kit on Friday, namely, “Hightop SARS-CoV-2 IgM/IgG Antibody”, bringing the total number of Covid-19 approved test kits to 30.
